Clinical Trial Update: Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and antifungal activity of recombinant interferon-gamma 1b added to standard therapy in cryptococcal meningitis patients, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis
• HIV Infection

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Meningitis, Cryptococcal, HIV Infections | Phase 2 | Status: COMPLETED